Home » Newsletters » BioWorld Asia

BioWorld Asia

May 14, 2003

View Archived Issues

Longtime U.S. Investor Adds Perspective To GLSV Venture

MUNICH, Germany - Is this the worst bear market he's ever seen in biotechnology? (BioWorld International) Read More

QLT, Xenova Suffer Setback As Pivotal Tariquidar Trial Stopped

Molecular Zipper Helps Bind Bacteria To Human Host Cells

European Ministers Review Plan To Implement Biotech Strategy

Acambis Benefits From U.S. Consolidation Of Contracts

UK Industry Riding Out Downturn, Surviving Till Sector Turns Around

Tel Aviv University Forms Fund To Push Commercial Potential

Vivalis Licenses Stem Cell Lines To Aventis For Vaccine Production

Axaron Cutback To Focus On Stroke Reflects German Sector

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...